Rezolute Inc - (NV) — Quarterly Financial Statistics (NASDAQ:RZLT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -22 M-17.43 M-20.32 M -77.15 M Cash from investing activities 346 K-68.49 M22.81 M -22.28 M Cash from financing activities 101.16 M911 K356 K 102.44 M Free cash flow -22 M-17.43 M-20.32 M -77.15 M

뉴스

Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

XOMA, TD Cowen, Generation Bio 인수 후 ’보유’ 재개

Alger Small Cap Growth Fund Q4 2025 Portfolio Update

제프리스, Rezolute 주식에 ’매수’ 등급 재확인, 목표가 4달러 유지

Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target

레졸루트, 희귀 질환 치료제 3상 시험에서 엇갈린 결과 발표

Rezolute shares mixed results from Phase 3 trial for rare disease therapy

XOMA, Leerink Partners, "매수" 등급 재확인, 목표가 45달러

Leerink Partners reiterates Outperform rating on XOMA stock at $45 target

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know

레졸루트 CFO, 79,577달러 상당의 주식 매입